| COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings C Delorme, O Paccoud, A Kas, A Hesters, S Bombois, P Shambrook, ... European journal of neurology 27 (12), 2651-2657, 2020 | 197 | 2020 |
| The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study A Kas, M Soret, N Pyatigoskaya, MO Habert, A Hesters, L Le Guennec, ... European journal of nuclear medicine and molecular imaging 48 (8), 2543-2557, 2021 | 166 | 2021 |
| Report on electroencephalographic findings in critically ill patients with COVID‐19 H Vespignani, D Colas, BS Lavin, C Soufflet, L Maillard, V Pourcher, ... Annals of Neurology 88 (3), 626-630, 2020 | 71 | 2020 |
| Neutrophil–platelet and monocyte–platelet aggregates in COVID-19 patients A Le Joncour, L Biard, M Vautier, H Bugaut, A Mekinian, G Maalouf, ... Thrombosis and haemostasis 120 (12), 1733-1735, 2020 | 59 | 2020 |
| Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital O Paccoud, F Tubach, A Baptiste, A Bleibtreu, D Hajage, G Monsel, ... Clinical Infectious Diseases 73 (11), e4064-e4072, 2021 | 53 | 2021 |
| Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting O Paccoud, J Guitard, M Labopin, L Surgers, F Malard, G Battipaglia, ... Bone Marrow Transplantation 55 (1), 93-99, 2020 | 33 | 2020 |
| Pre-emptive rituximab treatment for Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a … N Stocker, M Labopin, I Boussen, O Paccoud, A Bonnin, F Malard, ... Bone Marrow Transplantation 55 (3), 586-594, 2020 | 24 | 2020 |
| Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations R Palich, M Wirden, G Peytavin, MP Lê, S Seang, B Abdi, L Schneider, ... Journal of Antimicrobial Chemotherapy 75 (10), 2981-2985, 2020 | 21 | 2020 |
| Improving diagnosis of pulmonary mucormycosis: leads from a contemporary national study of 114 cases A Coste, A Conrad, R Porcher, S Poirée, P Peterlin, C Defrance, ... Chest 164 (5), 1097-1107, 2023 | 20 | 2023 |
| Infection par le virus de l’hépatite B: histoire naturelle, manifestations cliniques et principes thérapeutiques O Paccoud, L Surgers, K Lacombe La Revue de medecine interne 40 (9), 590-598, 2019 | 19 | 2019 |
| Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing … A Maillard, T Delory, J Bernier, A Villa, K Chaibi, L Escaut, A Contejean, ... International Journal of Antimicrobial Agents 62 (1), 106809, 2023 | 18 | 2023 |
| Simple and accurate quantitative analysis of cefiderocol and ceftobiprole in human plasma using liquid chromatography-isotope dilution tandem mass spectrometry: interest for … B Llopis, A Bleibtreu, D Schlemmer, P Robidou, O Paccoud, N Tissot, ... Clinical Chemistry and Laboratory Medicine (CCLM) 59 (11), 1800-1810, 2021 | 17 | 2021 |
| Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19 N Zahr, S Urien, B Llopis, V Pourcher, O Paccoud, A Bleibtreu, J Mayaux, ... Therapies 76 (4), 285-295, 2021 | 17 | 2021 |
| Hepatitis B virus infection: natural history, clinical manifestations and therapeutic approach O Paccoud, L Surgers, K Lacombe La Revue de Médecine Interne 40 (9), 590-598, 2019 | 14 | 2019 |
| Main human inborn errors of immunity leading to fungal infections C Cifaldi, GM Ursu, I D'Alba, O Paccoud, F Danion, F Lanternier, ... Clinical Microbiology and Infection 28 (11), 1435-1440, 2022 | 13 | 2022 |
| Prevalence and factors associated with symptom persistence: a prospective study of 429 mild COVID-19 outpatients A Faycal, AL Ndoadoumgue, B Sellem, C Blanc, Y Dudoit, L Schneider, ... Infectious diseases now 52 (2), 75-81, 2022 | 13 | 2022 |
| Impact of intravenous and subcutaneous immunoglobulins on false positivity of galactomannan and β-D-glucan antigenaemia and detection of circulating Aspergillus fumigatus DNA ME Bougnoux, C Angebault, O Paccoud, H Coignard, F Lanternier, ... Clinical Microbiology and Infection 26 (8), 1101-1102, 2020 | 13 | 2020 |
| Current spectrum of infections in patients with X-linked Agammaglobulinemia O Paccoud, N Mahlaoui, D Moshous, C Aguilar, B Neven, F Lanternier, ... Journal of Clinical Immunology 41 (6), 1266-1271, 2021 | 11 | 2021 |
| Epidemiology and prognostic factors of mucormycosis in France (2012–2022): a cross-sectional study nested in a prospective surveillance programme L Gouzien, D Che, S Cassaing, O Lortholary, V Letscher-Bru, O Paccoud, ... The Lancet Regional Health–Europe 45, 2024 | 10 | 2024 |
| on the behalf of CoCo-Neurosciences study group and COVID SMIT PSL study group The cerebral network of COVID-19-related encephalopathy: A longitudinal voxel-based 18F-FDG-PET study A Kas, M Soret, N Pyatigoskaya, MO Habert, A Hesters, L Le Guennec, ... Eur. J. Nucl. Med. Mol. Imaging 48, 2543-2557, 2021 | 10 | 2021 |
